Apellis Pharmaceuticals Inc
APLS
|
|
| |
|
| Trading Volume | 49,668 |
|
|
72.47 - 33.64 |
| Market Cap Full | $ 4.6B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 4.8% | -1.9% | 27.6% | 7.5% |
| Q2 | - | -30.4% | 38.1% | -11% |
| Q3 | - | -2.4% | -58.2% | 51% |
| Q4 | - | 12.4% | 61.2% | -24.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 5.7 | -2.1 | -5.2 | -19.1 | -17.4 | 5.8 | -4.6 | -2.4 | - | - | - | -6 |
| 2023 | |||||||||||
| 2 | 24.2 | 0.7 | 26.5 | 2.9 | 6.1 | -71.7 | 63.9 | -9.9 | 27.9 | 10.7 | 11.1 |
| 2022 | |||||||||||
| -15.9 | 5.9 | 20.6 | -14.3 | -4.8 | 9.1 | 24.5 | 7.5 | 12.9 | -11.4 | -17.5 | 3.6 |
| 2021 | |||||||||||
| -22.6 | 8.8 | -10.9 | 18.1 | 13.6 | 9.8 | 5.7 | -1.4 | -50 | -6.7 | 36.9 | 12.4 |
| 2020 | |||||||||||
| 32.3 | -19 | -17.6 | 27.9 | -1.7 | -3.1 | -20.7 | 18.5 | -2.1 | 6.2 | 47.8 | 21.3 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.6 | -1.4 | -2.3 | -2.3 |
| Q2 | -1 | -1.5 | -2.7 | -1.6 |
| Q3 | -1.2 | -1.8 | -2.3 | -1.8 |
| Q4 | 0 | -1.5 | -1.5 | 1.1 |
| A | -3.75 | -6.2 | -8.8 | -4.6 |